Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Limited has informed the stock exchanges that the trading window for dealing in the company's shares is closed for designated persons and insiders, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. This means directors, key managerial personnel, connected employees, and their immediate relatives cannot buy or sell the company's stock during this restricted period. The trading window closure is a routine compliance measure, typically enforced ahead of the declaration of financial results to prevent insider trading. No specific duration or reopening date has been mentioned in the headline, but the window usually reopens 48 hours after results are publicly announced.
This is a routine regulatory compliance announcement and does not directly impact the stock price or shareholders. It simply restricts insiders from trading during a sensitive period, which is a standard governance practice.